OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
August 10, 2022
Catalent will acquire Metrics Contract Services for $475 million to expand high-potent capabilities and oral development and manufacturing capacity.
FDA has approved Coherus’ Cimerli (ranibizumab-eqrn) as an interchangeable biosimilar for all five indications of Lucentis.
Sanofi and Innovent have entered into a strategic collaboration to accelerate development of oncology medicines and expand their presence in China.
Democrats approve curbs for Medicare plans, but not for commercial drug coverage.
August 05, 2022
La Jolla’s acquisition of Carterra’s LSA Platform is designed to advance their immunological and infectious disease research.
August 04, 2022
Better clinical data are needed, as well as strategies for tackling opioid abuse, tobacco use, and food safety.
August 02, 2022
CRYOPDP is expanding its footprint to Spain with its acquisition of Polar Expres.
Novasep-PharmaZell will increase API production capacity at its Mourenx site with €7.3M investment.
Pharma’s leveraging real-world evidence to drive product approval, reimbursement, and market access.
FDA’s hybrid inspection model will remain a regular means for supplementing onsite inspections and will be further integrated into the agency’s oversight operations.